A new study documents sweeping closures of H.I.V. treatment facilities across the United States following federal funding cuts. Researchers found that approximately 1,700 H.I.V. care sites shuttered after reductions to Ryan White HIV/AIDS Program funding, the largest federal initiative dedicated to treatment and services for people living with H.I.V.

The closures have created dangerous gaps in care access. Children living with H.I.V. and adults at highest risk of infection experienced the most severe disruptions. Rural communities and underserved urban areas lost disproportionate numbers of treatment centers, leaving vulnerable populations without nearby medical options.

H.I.V. treatment requires consistent access to antiretroviral therapy and ongoing clinical support. When patients lose established relationships with care providers, adherence drops. Missed doses allow the virus to develop drug resistance, threatening both individual health outcomes and broader public health efforts to suppress transmission.

The research demonstrates that funding cuts at the federal level translate directly into healthcare infrastructure loss. Each closed clinic represents not just a building but eliminated positions for nurses, counselors, and social workers who helped patients navigate treatment and manage complex health needs.

The Ryan White program serves approximately 500,000 people annually across the country. Program funding supports not only H.I.V. care but also prevention services, testing sites, and wraparound support including housing assistance and mental health services.

Restoring funding to these treatment networks matters for controlling H.I.V. transmission nationally. People on effective antiretroviral therapy cannot transmit the virus sexually, a principle known as undetectable equals untransmittable. Interrupted care undermines this progress. The researchers emphasize that rebuilding closed facilities requires time and resources, meaning gaps in access could persist for years even after funding restoration.

For people living with H.I.V., treatment continuity remains essential.